MIST Stock Earnings: Milestone Pharmaceuticals Beats EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
MIST stock results show that Milestone Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.
The post MIST Stock Earnings: Milestone Pharmaceuticals Beats EPS for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace